Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR.
The item "Diluted-EPS" stands at 11.15 Euros for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Sanofi SA's third quarter result of 2.27 EUR for the item "Diluted EPS" represents a decrease of -51.91 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 2.27 EUR for the item "Diluted EPS" represents an increase of 1.08 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 11.15 EUR for the item "Diluted EPS" represents an increase of 0.22 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 209.76 percent compared to the value the year prior.
The 1 year change in percent is 209.76.
The 3 year change in percent is 118.49.
The 5 year change in percent is 24.59.
The 10 year change in percent is 175.85.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted EPS | 905,699,262,464.00 |
![]() | Johnson & Johnson - Diluted EPS | 486,508,953,600.00 |
![]() | AbbVie Inc - Diluted EPS | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted EPS | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted EPS | 280,205,508,085.11 |